## **Core Concept**
The management of hyperthyroidism during pregnancy requires careful consideration to ensure both the mother's and fetus's safety. The primary goal is to control symptoms while minimizing risks to the fetus. **Propylthiouracil (PTU) and Methimazole (MMI)** are the two most commonly used antithyroid drugs.

## **Why the Correct Answer is Right**
Propylthiouracil (PTU) is generally considered the drug of choice for treating hyperthyroidism during the **first trimester** of pregnancy due to the lower risk of **congenital anomalies** compared to Methimazole (MMI). MMI is associated with a higher risk of **esophageal atresia** and **choanal atresia**. PTU works by inhibiting the synthesis of thyroid hormones and has a faster onset of action. However, due to the risk of **liver toxicity** associated with PTU, it is often switched to MMI after the first trimester if necessary.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Methimazole (MMI) is not the preferred choice during the first trimester due to its association with congenital anomalies.
* **Option B:** Radioactive iodine ablation is contraindicated in pregnancy because it can destroy the fetal thyroid gland.
* **Option D:** Beta-blockers are used to manage symptoms such as tachycardia and tremors but are not used as a definitive treatment for hyperthyroidism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Propylthiouracil (PTU) is preferred in the first trimester**, while **Methimazole (MMI) may be used in the second and third trimesters** due to the lower risk of liver toxicity with MMI. Always consider the trimester-specific risks when managing hyperthyroidism in pregnancy.

## **Correct Answer:** . Methimazole is not correct; the correct answer provided is .